financetom
Business
financetom
/
Business
/
WM Technology Q3 revenue slightly misses estimates, net income declines
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
WM Technology Q3 revenue slightly misses estimates, net income declines
Nov 6, 2025 2:20 PM

Overview

* WM Technology ( MAPS ) Q3 revenue slightly missed analyst expectations, declining from prior year

* Net income for Q3 decreased to $3.6 mln from $5.3 mln year-over-year

* Company's cash increased to $62.6 mln, reflecting strong balance sheet management

Outlook

* WM Technology estimates Q4 2025 revenue between $41 mln and $43 mln

* Company expects Q4 2025 Adjusted EBITDA of $5 mln to $7 mln

Result Drivers

* INDUSTRY PRESSURES - Revenue decline attributed to ongoing challenges in core markets, including pricing pressure affecting client margins and marketing budgets

* CLIENT ACQUISITION - Increase in average monthly paying clients due to new client acquisitions in developing markets, offset by churn in established markets

* SPENDING DECLINE - Decrease in average monthly revenues per paying client due to spend declines in established markets and lower spend levels from new clients

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Slight $42.18 $42.50

Revenue Miss* mln mln (2

Analysts

)

Q3 Net $3.64

Income mln

Q3 $3.65

Pretax mln

Profit

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the software peer group is "buy"

* Wall Street's median 12-month price target for WM Technology Inc ( MAPS ) is $2.61, about 60.9% above its November 5 closing price of $1.02

* The stock recently traded at 6 times the next 12-month earnings vs. a P/E of 5 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Microsoft's LinkedIn settles lawsuit claiming it overcharged advertisers
Microsoft's LinkedIn settles lawsuit claiming it overcharged advertisers
Jul 26, 2024
(Reuters) - LinkedIn agreed to pay $6.625 million to settle a proposed class action accusing the Microsoft ( MSFT ) unit of overcharging advertisers by inflating how many people watched video ads on its platform. A preliminary settlement was filed late Thursday in San Jose, California federal court, and requires approval by U.S. Magistrate Judge Susan van Keulen in San...
Union Pacific interfered in federal safety audit -- senator
Union Pacific interfered in federal safety audit -- senator
Jul 26, 2024
(Reuters) - U.S. railroad Union Pacific ( UNP ) interfered in a federal safety audit after employees were coached in how to respond, prompting the rail agency to end the review, the chair of the Senate Commerce Committee said Friday. Senator Maria Cantwell said she wants answers about Union Pacific's ( UNP ) actions after the Federal Railroad Administration told...
Newell Brands Shares Surge On Strong Q2 Earnings Beat And Upgraded FY24 Outlook Despite Revenue Dip
Newell Brands Shares Surge On Strong Q2 Earnings Beat And Upgraded FY24 Outlook Despite Revenue Dip
Jul 26, 2024
Newell Brands Inc. ( NWL ) shares are trading higher, fueled by better-than-expected second-quarter earnings and a raised FY24 outlook. The company reported adjusted earnings per share of 36 cents, beating the analyst consensus of 21 cents. Second quarter net sales were $2.03 billion, a 7.8% decline from the prior year period. Sales missed the street view of $2.046 billion....
US FDA warns of dosing errors with compounded versions of Novo's weight loss drugs
US FDA warns of dosing errors with compounded versions of Novo's weight loss drugs
Jul 26, 2024
July 26 (Reuters) - The U.S. Food and Drug Administration on Friday warned patients and doctors about dosing errors associated with compounded versions of Novo Nordisk's weight loss and diabetes drugs. (Reporting by Mariam Sunny in Bengaluru; Editing by Shinjini Ganguli) ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved